Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Companies in the Foresite Capital Management V portfolio as of the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cullinan Oncology (CGEM) 27.7 $70M 2.7M 25.75
Quantum-Si Incorporated Com Cl A 11.3 $29M NEW 2.3M 12.26
Aclaris Therapeutics (ACRS) 8.7 $22M 1.3M 17.56
Kinnate Biopharma (KNTE) 8.0 $20M 875k 23.28
Gemini Therapeutics (GMTX) 6.2 $16M 2.4M 6.47
Relay Therapeutics (RLAY) 5.8 $15M 400k 36.59
Alx Oncology Hldgs (ALXO) 5.0 $13M -27% 231k 54.68
Nurix Therapeutics (NRIX) 4.7 $12M 452k 26.53
Hims & Hers Health Com Cl A (HIMS) 4.5 $12M 1.1M 10.89
Population Health Investment Unit (PHICU) 3.8 $9.7M 960k 10.15
23andMe Holding Com Cl A 3.2 $8.2M NEW 700k 11.69
Pharvaris N V (PHVS) 2.7 $6.8M -45% 364k 18.63
FS Development Corp. II Com Cl A (FSII) 2.4 $6.0M 603k 9.98
Research Alliance Corp. II Com Cl A (RACB) 2.0 $5.1M 500k 10.14

Setup an alert

Foresite Capital Management V will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Bctg Acquisition Corp (BCTG) 1.8 $4.6M 400k 11.38
Lucira Health (LHDX) 1.3 $3.2M 485k 6.64
Helix Acquisition Corp. Com Cl A (HLXA) 1.0 $2.6M 250k 10.35

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020